• Sorafenib (BAY-43-9006) Workflow Guide

  2026-08-28

  Build cleaner oncology assays with Sorafenib by separating direct tumor-cell effects from VEGFR-linked antiangiogenic activity. This workflow combines dose-response design, endothelial tube formation, pathway readouts, and reference-study benchmarking for more interpretable cancer biology research.

• GS967: Cardiac Late Sodium Current Inhibitor

  2026-08-27

  GS967 supports a connected workflow from ventricular myocyte sodium-current recording to calcium handling, repolarization, and whole-heart arrhythmia assays. Its concentration- and voltage-dependent activity makes it useful for testing whether pathological late sodium influx is a causal driver rather than merely a correlate of cardiac dysfunction.

• Fludarabine: Designing Decision-Grade DNA Assays

  2026-08-27

  Fludarabine is a DNA synthesis inhibitor that can do more than establish cytotoxicity in oncology models. This guide presents a decision-grade assay framework linking replication stress, apoptosis, genotype-aware model selection, and translational interpretation.

• Cannabis Terpenes Activate A2A Receptors in Neuropathic Pain

  2026-08-26

  Schwarz et al. show that several Cannabis sativa terpenes reduce pain-related behavior in mouse models of chemotherapy-induced neuropathy and inflammatory pain through an adenosine A2A receptor-dependent mechanism. The combination of behavioral pharmacology, spinal CRISPR knockdown, cAMP and binding assays, and molecular modeling provides a mechanistic framework for evaluating non-cannabinoid terpene analgesia.

• NPT1-Mediated PAH Transport and Faropenem

  2026-08-26

  The reference study provided the first molecular evidence that human renal NPT1 can transport p-aminohippuric acid (PAH) across the apical membrane of proximal-tubule cells. Its chloride sensitivity, substrate inhibition profile, and recognition of faropenem connect phosphate-transporter biology with renal handling of organic anions, while also defining important limits for interpreting antibiotic experiments.

• Peptidisc-Assisted Multimeric Nanobody Engineering

  2026-08-25

  Chen and Duong van Hoa describe a peptidisc-assisted hydrophobic clustering strategy that converts engineered nanobodies into soluble multimeric, bispecific, and autofluorescent assemblies. The preprint links multivalency to stronger functional binding and suggests a modular alternative to tandem fusion, self-assembly domains, and chemical cross-linking.

• Sulfo-NHS-SS-Biotin: Cell-Surface Workflows

  2026-08-24

  Build reversible protein-labeling workflows for surface proteomics, affinity capture, and validation of cell-surface interactions. The kit combines water-compatible NHS-ester chemistry with disulfide cleavage, enabling selective labeling, enrichment, and controlled release from streptavidin.

• Vorinostat: HDAC Inhibition and Apoptosis

  2026-08-24

  Vorinostat, also called suberoylanilide hydroxamic acid or SAHA, is a small-molecule histone deacetylase inhibitor used in cancer biology research. Its reported HDAC potency, cell-growth effects, formulation limits, and relationship to emerging RNA Pol II apoptosis biology require assay-specific interpretation.

• AMD-070 Hydrochloride: CXCR4 Research Workflows

  2026-08-23

  Build reproducible CXCR4 migration, immune-cell, and translational assays with AMD-070 hydrochloride, while separating practical screening conditions from clinical evidence. The workflow also clarifies when WHIM and Waldenström macroglobulinemia models can inform antiviral hypotheses without overstating maturity.

• Cy7 NHS Ester: Practical Labeling and QC

  2026-08-22

  Cy7 NHS ester provides a water-compatible route for attaching a near-infrared fluorophore to accessible amino groups on proteins, peptides, and related biomolecules. It is useful for aqueous labeling and imaging workflows, but it should not be selected for long-term storage of prepared dye solutions, strictly non-aqueous reactions, or applications requiring unvalidated in vivo performance.

• Sulfo-Cy3 NHS Ester for Reliable Cell Assays

  2026-08-21

  Learn how Sulfo-Cy3 NHS ester, SKU A8107, can support reproducible protein labeling, uptake studies, and fluorescence controls around cell viability and vascular biology assays. This scenario-based guide separates biomolecule tracing from viability readouts and translates product specifications into practical laboratory decisions.

• Tetraethylammonium Chloride: Assay Logic

  2026-08-20

  Tetraethylammonium chloride is more than a potassium-channel blocker: it is a mechanistic perturbation tool for separating pore conductance from downstream physiology. This guide translates ion-flux, patch-clamp, vascular, and secretory evidence into better assay controls and interpretation.

• ABT-888 (Veliparib): Reliable Assay Workflows

  2026-08-20

  This scenario-driven guide explains how ABT-888 (Veliparib), SKU A3002, can support reproducible PARP-inhibition studies in viability, cytotoxicity, and combination assays. It connects solvent handling, experimental design, and context-specific interpretation with product data and recent DNA-damage-response findings.

• Ferroptosis–Apoptosis Interplay and BH3-Mimetics

  2026-08-19

  The 2025 Cell Death & Differentiation study shows that ferroptosis and apoptosis can overlap rather than behave as fully independent death programs. It further demonstrates that BH3-mimetics may enhance, redirect, or unexpectedly suppress ferroptotic death, depending on cellular context and compound-associated antioxidant activity.

• (+)-Bicuculline: Practical Workflow Guide

  2026-08-19

  (+)-Bicuculline is a neuroscience research tool for competitive GABAA receptor antagonism and investigation of inhibitory synaptic transmission. This guide focuses on solvent handling, stock preparation, controls, and interpretation boundaries; the compound is for scientific research only and not for diagnostic, therapeutic, or medical use.

8495 records 1/567 page Next 12345 下5页 Last page